Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CAREQiPSC

Financiado

Cerrado

Cartilage derived from equine induced pluripotent stem cells an in vitro and ex...

Cartilage derived from equine induced pluripotent stem cells an in vitro and ex vivo One Medicine approach for osteoarthritis Osteoarthritis is a degenerative joint pathology that constitutes the first cause of disability in older adults and accounts for >80% of chronic lameness in horses. Effective treatments are not available while developing them is o... ver más

31/01/2024

OLLSCOIL NA GAILLI...

185K€

Presupuesto del proyecto: 185K€

Líder del proyecto

UNIVERSITY OF GALWAY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2024-01-31

MSCA-IF-2020: Individual Fellowships

I+D

Cerrada hace 4 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

OLLSCOIL NA GAILLIMHE

184.59K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AutoCRAT Automated Cellular Robot Assisted Technologies for translati... 7M€ Cerrado

STEMREPAIR Novel mesenchymal stem cell based therapies for articular ca... 1M€ Cerrado

RTI2018-099389-A-I00 CRIOGELES ACTIVADOS POR GENES PARA REPARACION DE CARTILAGO 109K€ Cerrado

AGL2017-84411-P OPTIMIZACION DEL USO DE MSCS EN PATOLOGIAS ARTICULARES EN CA... 121K€ Cerrado

AGL2008-02428 TERAPIA CELULAR EN VETERINARIA: CARACTERIZACION DE CELULAS T... 115K€ Cerrado

EQC2018-005046-P UNIDAD EXPERIMENTAL DE TERAPIA REGENERATIVA EN PATOLOGÍAS OS... 292K€ Cerrado

Duración del proyecto: 33 meses Fecha Inicio: 2021-04-21
Fecha Fin: 2024-01-31

Líder del proyecto

UNIVERSITY OF GALWAY No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 185K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Osteoarthritis is a degenerative joint pathology that constitutes the first cause of disability in older adults and accounts for >80% of chronic lameness in horses. Effective treatments are not available while developing them is of utmost importance for the EU objective of translating knowledge into society’s benefit. Induced pluripotent stem cells (iPSCs) can provide unlimited cells for therapy with no ethical concerns. However, pre-clinical knowledge is limited to small animals with low translational potential. Larger species such as the horse better resembles human joint’s features and can also benefit from these therapies (One Medicine). To develop this approach, the first mandatory step is obtaining suitable cartilage from eqiPSCs. Thus, the goals of CAREQiPSC are: 1) establishing eqiPSCs from new sources with potential chondrogenic commitment, 2) derive mesenchymal-like cells with chondrogenic potential, 3) compare their chondrogenic ability under different conditions, 4) explore their therapeutic potential in an ex vivo cartilage explant system. To achieve these goals, eqiPSCs will be established from articular chondrocytes, umbilical cord mononuclear cells, and dermal fibroblasts, and their pluripotency will be studied. Mesenchymal cells derived from these lines will be characterised and induced to differentiate in the customary pellet system and in a 3D scaffold. The tissue obtained will be studied by histology, protein and gene expression, and its therapeutic potential will be investigated in cartilage explants, also including imaging and biomechanical assessment. The researcher’s previous experience in the equine model and the host’s expertise in iPSCs and infrastructure will ensure the achievement of these goals. The main outcome will be critical in vitro and ex vivo knowledge to facilitate in vivo application in the horse, which will generate preclinical information transferable to human therapy and will advance the veterinary medicine field.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores